Kyndryl price target raised to $16 from $14 at BMO Capital
bullish
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
bullish
What happened, with direct paths to the underlying reporting
BMO Capital raises KD target to $16 from $14; current price $13.90; price since signal up by $0.86.
Target: $16
Posted price: $13.9
Analyst firm: BMO Capital
Analyst: Keith Bachman
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.